NEW YORK and VIENNA, Austria, Jan. 08, 2025 (GLOBE NEWSWIRE) — FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFERRules 8.1 and 8.2 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: HOOKIPA Pharma Inc.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree HOOKIPA Pharma Inc. (Offeror)(d)   Is the discloser the offeror or the offeree? Offeror(e)   Date position held:        The latest practicable date prior to the disclosure 7 January 2025(f)   In...

AMENDED DISCLOSURE – PLEASE REFER TO SECTIONS 2(a) AND 3(a) 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Learning Technologies Group Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date...

TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) — Kolter Capital NWH LLC (Kolter Capital), an affiliate of the Kolter Group LLC (Kolter Group) announced today that it has acquired an additional 100,000 units (Units) of Northwest Healthcare Properties Real Estate Investment Trust (the REIT) in the open market through the facilities of the Toronto Stock Exchange at an average price of CAD$4.6169 per Unit, for an aggregate purchase price of CAD$461,690 (the Acquisition). Immediately prior to completion of the Acquisition, Kolter Capital beneficially owned or exercised control or direction over 24,663,400 Units, representing approximately 9.99% of the issued and outstanding Units. Upon completion of the Acquisition, Kolter Capital now beneficially owns or exercises control or direction over 24,763,400 Units, representing approximately 10.03%...

Bateau Asset Management brings to SMC Entertainment:Foundational acquisition into International Financial Services Sector Well-established client base of high-net-worth individuals Experienced global client services team based in Australia and Singapore Research and advisory capabilities complementary to SMC Entertainment’s Fintech platformBOCA RATON, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) — SMC Entertainment, Inc. (“SMC” or the “Company”) (OTC PINK: SMCE), a Fintech incubator company focused on acquisition and support of commercialized financial services and technology (Fintech) companies, is pleased to announce that it has closed the Acquisition Agreement to acquire a 100% interest in Australia-based Bateau Asset Management, a boutique investment manager (“Bateau”). The acquisition will provide SMC with...

All-Stock Acquisition Strategy Targets Multiple Small Companies with FDA-Approved Products to Drive Growth and Shareholder Value WARRINGTON, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced it has launched a new corporate strategy to become a revenue generating biotech company through acquisitions of small companies and their FDA-approved products while the Company continues to progress its cardiovascular and oncology development pipeline. The Company will seek acquisition targets to achieve the Company’s new corporate strategy. Windtree believes there is an opportunity in the market: the acquisition of small companies with FDA-approved...

Downing LLPLEI: 213800G3X76VBG9SB50408 January 2025Form 8.3 re. Team Internet Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Downing LLP(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):Client funds managed by Downing LLP(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:Team Internet Group Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: n/a(e)   Date position held/dealing undertaken:07 January 2025(f)   In addition to the company in 1(c) above, is the discloser making disclosures...

On January 7, 2025, Hydro finalized the open market repurchase of the 2024-2025 buyback program as announced on September 10, 2024. The total program comprises 30 526 862 shares, of which 20 067 969 shares were repurchased in the market. The remaining 10 458 893 shares will be purchased from the Norwegian state through the Ministry of Trade, Industry and Fisheries, and therefore the Ministry’s ownership interest in Norsk Hydro ASA of 34.26% will remain unchanged. The 30 526 862 shares will be cancelled following approval by the Annual General Meeting in May 2025. The shares that have been repurchased in the open market have had an immediate cash effect, whereas the pro rata shares from the Norwegian state will be paid simultaneously with the capital reduction in mid-2025. The weighted average price for the 20 067 969 shares was NOK...

Nykredit publishes offer document concerning the takeover offer, and Spar Nord publishes the board of directors’ statement NOT FOR DIRECT OR INDIRECT RELEASE, PUBLICATION OR DISTRIBUTION IN OR TO ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE CONTRARY TO APPLICABLE LEGISLATION OR RULES OF SUCH JURISDICTION In continuation of the entering into of a publication agreement (the Publication Agreement) between Spar Nord Bank A/S (Spar Nord) and Nykredit Realkredit A/S (Nykredit) on 10 December 2024 (cf. company announcement no. 73) concerning Nykredit’s decision to make an all-cash voluntary takeover offer for all shares (other than treasury shares held by Spar Nord) in Spar Nord (the Offer), Nykredit has today, in accordance with section 4 (2) and 21 of the Danish Executive Order no. 636 of 15 May 2020 on Takeover...

THIS ANNOUNCEMENT IS PUBLISHED PURSUANT TO SECTION 4(2) OF EXECUTIVE ORDER NO. 636 OF 15 MAY 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE DOING SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. Publication of offer document for Nykredit’s recommended voluntary public tender offer for Spar Nord Bank A/S 8 January 2025 Nykredit publishes offer document concerning recommended voluntary public tender offer for Spar Nord Bank A/S In accordance with section 4(1) of the Danish Takeover Order1, Nykredit Realkredit A/S (“Nykredit”) announced on 10 December 2024 that Nykredit intended to submit a voluntary public tender offer (the “Offer”) to acquire all shares in Spar Nord Bank A/S (“Spar Nord Bank”), with the exception of Spar Nord Bank’s treasury...

Vabysmo Sales Accounts For More Than 35% Of Global Bispecific Antibodies Market Says Kuick Research Delhi, Jan. 07, 2025 (GLOBE NEWSWIRE) — Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights:Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2024) Global Bispecific Antibodies Market Size 2024: > USD 8.5 Billion Global Bispecific Antibodies Market Forecast Till 2029 Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2024) Approved Bispecific Antibodies Regional Sales (2018 till 2024) Clinical and Commercial Insight On Approved Bispecific Antibodies: 16 Antibodies Approved Bispecific Antibodies Pricing and Dosage Analysis Global Bispecific Antibodies...